Leef Brands (LEEEF) Invested Capital (2024 - 2026)

Leef Brands (LEEEF) posted Invested Capital of $105000.0 for Q1 2026, down 69.12% sequentially from $340000.0 in Q4 2025.

Leef Brands (LEEEF) Invested Capital (2024 - 2026) Analysis & Trends

Leef Brands has reported Invested Capital for 3 years, with the latest figure at $105000.0 in Q1 2026.

Quarterly Invested Capital changed N/A year-over-year to $105000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $945000.0 (changed N/A YoY) and the FY2025 annual result came in at $340000.0, down 32.0% from the prior year.
Invested Capital fell to $105000.0 in Q1 2026 per LEEEF's latest filing, from $340000.0 in the prior quarter.
Over five years, Invested Capital peaked at $500000.0 in Q4 2024 and troughed at $105000.0 in Q1 2026.
A 3-year average of $315000.0 and a median of $340000.0 in 2025 frame the typical range for Invested Capital.
The widest YoY moves for Invested Capital: up 32.0% in 2025, down 32.0% in 2025.
Over 3 years, Invested Capital stood at $500000.0 in 2024, then slumped by 32.0% to $340000.0 in 2025, then tumbled by 69.12% to $105000.0 in 2026.
According to Business Quant data, Invested Capital over the past three periods registered $105000.0, $340000.0, and $500000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	4.50 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	630.00 Mn
10	Leef Brands	58.70 Mn	53.75 Mn	2.41 Mn	-

Download Data